Precision glycocalyx editing as a strategy for cancer immunotherapy
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Precision glycocalyx editing as a strategy for cancer immunotherapy
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 113, Issue 37, Pages 10304-10309
Publisher
Proceedings of the National Academy of Sciences
Online
2016-08-23
DOI
10.1073/pnas.1608069113
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sialic acid-modified antigens impose tolerance via inhibition of T-cell proliferation and de novo induction of regulatory T cells
- (2016) Maurizio Perdicchio et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dual antibody therapy to harness the innate anti-tumor immune response to enhance antibody targeting of tumors
- (2015) Cariad Chester et al. CURRENT OPINION IN IMMUNOLOGY
- Macrophages are critical effectors of antibody therapies for cancer
- (2015) Kipp Weiskopf et al. mAbs
- Therapeutic antibodies: their mechanisms of action and the pathological findings they induce in toxicity studies
- (2015) Masami Suzuki et al. Journal of Toxicologic Pathology
- The Application of Natural Killer Cell Immunotherapy for the Treatment of Cancer
- (2015) Katayoun Rezvani et al. Frontiers in Immunology
- Aldehyde Tag Coupled with HIPS Chemistry Enables the Production of ADCs Conjugated Site-Specifically to Different Antibody Regions with Distinct in Vivo Efficacy and PK Outcomes
- (2014) Penelope M. Drake et al. BIOCONJUGATE CHEMISTRY
- Sialic Acids Sweeten a Tumor's Life
- (2014) C. Bull et al. CANCER RESEARCH
- Cancer intelligence acquired (CIA): tumor glycosylation and sialylation codes dismantling antitumor defense
- (2014) Kayluz Frias Boligan et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Interactions between Siglec-7/9 receptors and ligands influence NK cell–dependent tumor immunosurveillance
- (2014) Camilla Jandus et al. JOURNAL OF CLINICAL INVESTIGATION
- Structural basis for sialic acid–mediated self-recognition by complement factor H
- (2014) Bärbel S Blaum et al. Nature Chemical Biology
- Engagement of myelomonocytic Siglecs by tumor-associated ligands modulates the innate immune response to cancer
- (2014) Heinz Läubli et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structural basis for simultaneous recognition of an O-glycan and its attached peptide of mucin family by immune receptor PILR
- (2014) K. Kuroki et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dual Blockade of PD-1 and CTLA-4 Combined with Tumor Vaccine Effectively Restores T-Cell Rejection Function in Tumors
- (2013) J. Duraiswamy et al. CANCER RESEARCH
- Cellular and molecular mechanisms in cancer immune escape: a comprehensive review
- (2013) Alka Bhatia et al. Expert Review of Clinical Immunology
- Glycocalyx engineering reveals a Siglec-based mechanism for NK cell immunoevasion
- (2013) Jason E Hudak et al. Nature Chemical Biology
- Natural Killer Cell Mediated Antibody-Dependent Cellular Cytotoxicity in Tumor Immunotherapy with Therapeutic Antibodies
- (2013) Ursula J. E. Seidel et al. Frontiers in Immunology
- Sialidase Specificity Determined by Chemoselective Modification of Complex Sialylated Glycans
- (2012) Randy B. Parker et al. ACS Chemical Biology
- Synthesis of Heterobifunctional Protein Fusions Using Copper-Free Click Chemistry and the Aldehyde Tag
- (2012) Jason E. Hudak et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Multifarious roles of sialic acids in immunity
- (2012) Ajit Varki et al. Annals of the New York Academy of Sciences
- Site-specific chemical protein conjugation using genetically encoded aldehyde tags
- (2012) David Rabuka et al. Nature Protocols
- Immune Inhibitory Molecules LAG-3 and PD-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune Escape
- (2011) S.-R. Woo et al. CANCER RESEARCH
- Breast carcinomas with borderline (2+) HER2 immunohistochemistry: percentage of cells with complete membrane staining for HER2 and the frequency of HER2 amplification
- (2011) A. H. S. Lee et al. JOURNAL OF CLINICAL PATHOLOGY
- Immunomodulation of monocyte-derived dendritic cells through ligation of tumor-produced mucins to Siglec-9
- (2010) Mariko Ohta et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity
- (2010) Kaori Sakuishi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Sialylation of 3-Methylcholanthrene-Induced Fibrosarcoma Determines Antitumor Immune Responses during Immunoediting
- (2010) M. Cohen et al. JOURNAL OF IMMUNOLOGY
- PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors
- (2010) M. A. Curran et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search